{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:09:48Z","timestamp":1779368988110,"version":"3.53.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41433-026-04391-7","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:26:41Z","timestamp":1773163601000},"page":"1208-1214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and progression rates of geographic atrophy in an Asian population from Singapore"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2699-4339","authenticated-orcid":false,"given":"Farah NI","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenric RP","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiok Hong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9266-3589","authenticated-orcid":false,"given":"Anna CS","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-En","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin YC","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choi Mun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3358-3516","authenticated-orcid":false,"given":"Chui Ming Gemmy","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau J.","family":"Fenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"4391_CR1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.ophtha.2009.10.007","volume":"117","author":"R Kawasaki","year":"2010","unstructured":"Kawasaki R, Yasuda M, Song SJ, Chen SJ, Jonas JB, Wang JJ, et al. The prevalence of age-related macular degeneration in Asians. Ophthalmology. 2010;117:921\u20137.","journal-title":"Ophthalmology"},{"key":"4391_CR2","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","volume":"379","author":"LS Lim","year":"2012","unstructured":"Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379:1728\u201338.","journal-title":"Lancet"},{"key":"4391_CR3","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","volume":"402","author":"JS Heier","year":"2023","unstructured":"Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, et al. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet. 2023;402:1434\u201348.","journal-title":"Lancet"},{"key":"4391_CR4","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.ophtha.2013.11.023","volume":"121","author":"FG Holz","year":"2014","unstructured":"Holz FG, Strauss EC, Schmitz-Valckenberg S, van Lookeren Campagne M. Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology. 2014;121:1079\u201391.","journal-title":"Ophthalmology"},{"key":"4391_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/IAE.0000000000001392","volume":"37","author":"DS Boyer","year":"2017","unstructured":"Boyer DS, Schmidt-Erfurth U, van Lookeren Campagne M, Henry EC, Brittain C. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. RETINA. 2017;37:819\u201335.","journal-title":"RETINA"},{"key":"4391_CR6","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","volume":"402","author":"AM Khanani","year":"2023","unstructured":"Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, et al. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet. 2023;402:1449\u201358.","journal-title":"Lancet"},{"key":"4391_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.oret.2023.12.008","volume":"8","author":"LVD Priore","year":"2024","unstructured":"Priore LVD. To treat or not to treat geographic atrophy\u2013that is the question. Ophthalmol Retina. 2024;8:207\u20139.","journal-title":"Ophthalmol Retina"},{"key":"4391_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ajo.2024.02.021","volume":"263","author":"KG Csaky","year":"2024","unstructured":"Csaky KG, Miller JML, Martin DF, Johnson MW. Drug approval for the treatment of geographic atrophy: how we got here and where we need to go. Am J Ophthalmol. 2024;263:231\u20139.","journal-title":"Am J Ophthalmol"},{"key":"4391_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/17469899.2021.1951231","volume":"16","author":"F Corvi","year":"2021","unstructured":"Corvi F, Sadda SR. Progression of geographic atrophy. Expert Rev Ophthalmol. 2021;16:343\u201356.","journal-title":"Expert Rev Ophthalmol"},{"key":"4391_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","volume":"53","author":"CW Wong","year":"2016","unstructured":"Wong CW, Yanagi Y, Lee W-K, Ogura Y, Yeo I, Wong TY, et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retina Eye Res. 2016;53:107\u201339.","journal-title":"Prog Retina Eye Res"},{"key":"4391_CR11","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106\u2013e116.","journal-title":"Lancet Glob Health"},{"key":"4391_CR12","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.ophtha.2020.04.019","volume":"127","author":"TH Rim","year":"2020","unstructured":"Rim TH, Kawasaki R, Tham Y-C, Kang SW, Ruamviboonsuk P, Bikbov MM, et al. Prevalence and pattern of geographic atrophy in Asia: the Asian eye epidemiology consortium. Ophthalmology. 2020;127:1371\u201381.","journal-title":"Ophthalmology"},{"key":"4391_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","volume":"136","author":"FG Holz","year":"2018","unstructured":"Holz FG, Sadda SR, Busbee B, Chew EY, Mitchell P, Tufail A, et al. Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials. JAMA Ophthalmol. 2018;136:666\u201377.","journal-title":"JAMA Ophthalmol"},{"key":"4391_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ajo.2020.01.005","volume":"212","author":"NS Abdelfattah","year":"2020","unstructured":"Abdelfattah NS, Sadda J, Wang Z, Hu Z, Sadda S. Near-infrared reflectance imaging for quantification of atrophy associated with age-related macular degeneration. Am J Ophthalmol. 2020;212:169\u201374.","journal-title":"Am J Ophthalmol"},{"key":"4391_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, et al. Consensus definition for atrophy associated with age-related macular degeneration on OCT. Ophthalmology. 2018;125:537\u201348.","journal-title":"Ophthalmology"},{"key":"4391_CR16","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1167\/iovs.15-18682","volume":"57","author":"Z Wu","year":"2016","unstructured":"Wu Z, Ayton LN, Luu CD, Baird PN, Guymer RH. Reticular pseudodrusen in intermediate age-related macular degeneration: prevalence, detection, clinical, environmental and genetic associations. Investig Ophthalmol Vis Sci. 2016;57:1310\u20136.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4391_CR17","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/bjo.2004.057794","volume":"89","author":"A Bindewald","year":"2005","unstructured":"Bindewald A, Schmitz-Valckenberg S, Jorzik JJ, Dolar-Szczasny J, Sieber H, Keilhauer C, et al. Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Br J Ophthalmol. 2005;89:874\u20138.","journal-title":"Br J Ophthalmol"},{"key":"4391_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.oret.2019.10.019","volume":"4","author":"BJ Fenner","year":"2020","unstructured":"Fenner BJ, Ting DSW, Tan ACS, Teo K, Chan CM, Mathur R, et al. Real-world treatment outcomes of age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Ophthalmol Retina. 2020;4:403\u201314.","journal-title":"Ophthalmol Retina"},{"key":"4391_CR19","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","volume":"37","author":"SS Patel","year":"2023","unstructured":"Patel SS, Lally DR, Hsu J, Wykoff CC, Eichenbaum D, Heier JS, et al. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye. 2023;37:3551\u20137.","journal-title":"Eye"},{"key":"4391_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.oret.2022.12.013","volume":"7","author":"KYC Teo","year":"2023","unstructured":"Teo KYC, Fujimoto S, Sadda SR, Kokame G, Gomi F, Kim JE, et al. Geographic atrophy phenotypes in subjects of different ethnicity: Asia-Pacific Ocular Imaging Society Work Group Report 3. Ophthalmol Retina. 2023;7:593\u2013604.","journal-title":"Ophthalmol Retina"},{"key":"4391_CR21","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.oret.2023.06.004","volume":"7","author":"Y Sato","year":"2023","unstructured":"Sato Y, Ueda-Arakawa N, Takahashi A, Miyara Y, Hara C, Kitajima Y, et al. Clinical characteristics and progression of geographic atrophy in a Japanese population. Ophthalmol Retina. 2023;7:901\u20139.","journal-title":"Ophthalmol Retina"},{"key":"4391_CR22","doi-asserted-by":"crossref","unstructured":"Han YE, Choi HI, Lee J, Kim YJ, Lee JY, Sadda SR, et al. Geographic atrophy in Korean patients with dry age-related macular degeneration: incidence, phenotypes and progression. Can J Ophthalmol. 2024;60:e925\u2013e933.","DOI":"10.1016\/j.jcjo.2025.05.026"},{"key":"4391_CR23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00417-011-1620-1","volume":"249","author":"H Koizumi","year":"2011","unstructured":"Koizumi H, Yamagishi T, Yamazaki T, Kawasaki R, Kinoshita S. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249:1123\u20138.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4391_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ajo.2012.08.011","volume":"155","author":"N Ueda-Arakawa","year":"2013","unstructured":"Ueda-Arakawa N, Ooto S, Nakata I, Yamashiro K, Tsujikawa A, Oishi A, et al. Prevalence and genomic association of reticular pseudodrusen in age-related macular degeneration. Am J Ophthalmol. 2013;155:260\u2013269.e2.","journal-title":"Am J Ophthalmol"},{"key":"4391_CR25","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.ophtha.2016.06.025","volume":"123","author":"A Domalpally","year":"2016","unstructured":"Domalpally A, Danis R, Agr\u00f3n E, Blodi B, Clemons T, Chew E, et al. Evaluation of geographic atrophy from color photographs and fundus autofluorescence images: age-related eye disease study 2 report number 11. Ophthalmology. 2016;123:2401\u20137.","journal-title":"Ophthalmology"},{"key":"4391_CR26","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ajo.2008.05.050","volume":"146","author":"R Klein","year":"2008","unstructured":"Klein R, Meuer SM, Knudtson MD, Klein BEK. The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. Am J Ophthalmol. 2008;146:692\u20139.","journal-title":"Am J Ophthalmol"},{"key":"4391_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ophtha.2010.08.018","volume":"118","author":"Z Yehoshua","year":"2011","unstructured":"Yehoshua Z, Rosenfeld PJ, Gregori G, Feuer WJ, Falc\u00e3o M, Lujan BJ, et al. Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology. 2011;118:679\u201386.","journal-title":"Ophthalmology"},{"key":"4391_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1001\/jamaophthalmol.2013.572","volume":"131","author":"WJ Feuer","year":"2013","unstructured":"Feuer WJ, Yehoshua Z, Gregori G, Penha FM, Chew EY, Ferris FL, et al. Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26. JAMA Ophthalmol. 2013;131:110\u20131.","journal-title":"JAMA Ophthalmol"},{"key":"4391_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1586\/eop.13.3","volume":"8","author":"JZ Kuo","year":"2013","unstructured":"Kuo JZ, Wong TY, Ong FS. Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy. Expert Rev Ophthalmol. 2013;8:127\u201340.","journal-title":"Expert Rev Ophthalmol"},{"key":"4391_CR30","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.oret.2020.04.014","volume":"4","author":"M Biarn\u00e9s","year":"2020","unstructured":"Biarn\u00e9s M, Colijn JM, Sousa J, Ferraro LL, Garcia M, Verzijden T, et al. Genotype- and phenotype-based subgroups in geographic atrophy secondary to age-related macular degeneration: the eye-risk consortium. Ophthalmol Retina. 2020;4:1129\u201337.","journal-title":"Ophthalmol Retina"},{"key":"4391_CR31","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris","year":"2013","unstructured":"Ferris FL, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844\u201351.","journal-title":"Ophthalmology"},{"key":"4391_CR32","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.ophtha.2010.01.027","volume":"117","author":"SA Zweifel","year":"2010","unstructured":"Zweifel SA, Imamura Y, Spaide TC, Fujiwara T, Spaide RF. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology. 2010;117:1775\u201381.","journal-title":"Ophthalmology"},{"key":"4391_CR33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.oret.2020.11.011","volume":"5","author":"F Mano","year":"2021","unstructured":"Mano F, Sprehe N, Olsen TW. Association of drusen phenotype in age-related macular degeneration from human eye-bank eyes to disease stage and cause of death. Ophthalmol Retina. 2021;5:743\u20139.","journal-title":"Ophthalmol Retina"},{"key":"4391_CR34","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ophtha.2007.08.030","volume":"115","author":"ML Klein","year":"2008","unstructured":"Klein ML, Ferris FL, Armstrong J, Hwang TS, Chew EY, Bressler SB, et al. Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology. 2008;115:1026\u201331.","journal-title":"Ophthalmology"},{"key":"4391_CR35","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","volume":"125","author":"TD Keenan","year":"2018","unstructured":"Keenan TD, Agr\u00f3n E, Domalpally A, Clemons TE, van Asten F, Wong WT, et al. Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16. Ophthalmology. 2018;125:1913\u201328.","journal-title":"Ophthalmology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04391-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04391-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04391-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:59:20Z","timestamp":1779368360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04391-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4391"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04391-7","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"BJF: Consultant for Roche, Novartis, Bayer, Janssen. CMGC: Consultant\/ Speaker for Roche, Bayer, Boehringer Ingelheim, member of Eye editorial board. KYCT: Consultant for Roche, Novartis, Bayer. ACST: Consultant\/ Advisor for Novartis, Bayer, Roche, Zeiss, Nidek. The rest of the authors have no relevant financial disclosures","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}